Fosun International Ltd - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Fosun International Ltd ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$90,819,890
+36.1%
21,521,3010.0%14.58%
+55.9%
Q2 2023$66,716,032
+123.0%
21,521,3010.0%9.35%
+232.2%
Q1 2023$29,914,609
-30.2%
21,521,3010.0%2.82%
-20.0%
Q4 2022$42,827,417
-1.5%
21,521,3010.0%3.52%
-24.3%
Q3 2022$43,473,000
-36.5%
21,521,3010.0%4.65%
-51.0%
Q2 2022$68,438,000
-23.7%
21,521,3010.0%9.48%
+22.4%
Q1 2022$89,744,000
-12.9%
21,521,3010.0%7.75%
+31.5%
Q4 2021$103,087,000
-10.3%
21,521,3010.0%5.89%
+0.2%
Q3 2021$114,924,000
+4.3%
21,521,3010.0%5.88%
-10.1%
Q2 2021$110,189,000
-23.9%
21,521,3010.0%6.54%
-42.6%
Q1 2021$144,839,000
+47.3%
21,521,3010.0%11.40%
+77.5%
Q4 2020$98,351,000
+17.8%
21,521,3010.0%6.42%
-12.4%
Q3 2020$83,503,000
-18.5%
21,521,3010.0%7.34%
-25.4%
Q2 2020$102,442,000
+36.8%
21,521,3010.0%9.84%
+35.1%
Q1 2020$74,893,000
-27.8%
21,521,3010.0%7.28%
-15.6%
Q4 2019$103,733,000
+66.2%
21,521,3010.0%8.63%
+24.7%
Q3 2019$62,412,000
-55.5%
21,521,301
+10.1%
6.92%
-25.3%
Q2 2019$140,188,000
-49.4%
19,552,0010.0%9.26%
-47.4%
Q1 2019$277,052,000
+4.7%
19,552,0010.0%17.60%
+11.4%
Q4 2018$264,539,000
-39.0%
19,552,0010.0%15.80%
-24.0%
Q3 2018$433,859,000
+30.3%
19,552,001
-3.7%
20.80%
+22.3%
Q2 2018$333,013,00020,293,35117.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders